Axel Mark
3624
Renascience
4889
Ecomott
3987
斐詩特莉亞控股
2736
泰庫尼思科
2962
日本市場個股詳情
4017 Creema
- 239
- -6-2.45%
延時20分鐘行情已收盤 01/10 15:30 (東京)
16.10億總市值20.55市盈率(靜)
245最高價239最低價4.02萬股成交量241今開245昨收970.48萬成交額45052周最高1.39%換手率673.71萬總股本20052周最低14.74每股收益TTM6.89億流通值5700歷史最高20.55市盈率(靜)288.49萬流通股200歷史最低11.63每股收益(静)2.45%振幅--股息TTM1.56市淨率100股每手--股息率TTM
Creema關鍵統計數據
季報+年報
顯示同比
| (Q2)2024/08/31 | (Q1)2024/05/31 | (FY)2024/02/29 | (Q4)2024/02/29 | (Q3)2023/11/30 | (Q2)2023/08/31 | (Q1)2023/05/31 | (FY)2023/02/28 | (Q4)2023/02/28 | (Q3)2022/11/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業總收入 | -0.85%6.04億 | 2.22%6.44億 | 0.36%25.09億 | -2.53%7.01億 | -6.82%5.68億 | 5.56%6.09億 | 6.16%6.3億 | 8.95%25億 | 14.51%7.19億 | 9.46%6.1億 |
| 主營業務成本 | -2.11%1.33億 | 31.58%1.62億 | -12.19%5.2億 | -7.83%1.49億 | -33.82%1.12億 | -1.42%1.35億 | -0.21%1.23億 | 690.32%5.92億 | 373.01%1.61億 | 428.95%1.69億 |
| 毛利 | -0.49%4.71億 | -4.93%4.82億 | 4.24%19.89億 | -1.00%5.52億 | 3.56%4.56億 | 7.74%4.74億 | 7.84%5.07億 | -14.04%19.08億 | -6.09%5.58億 | -16.10%4.41億 |
| 營業費用 | -2.08%4.73億 | -5.83%4.64億 | -15.09%19.48億 | -19.29%5.04億 | -32.81%4.68億 | -7.54%4.83億 | 9.36%4.93億 | 20.92%22.94億 | 22.92%6.25億 | 46.22%6.96億 |
| 營業利潤 | 83.03%-157.5萬 | 26.79%1,777.5萬 | 110.74%4,143.7萬 | 171.25%4,784.5萬 | 95.63%-1,114.7萬 | 88.78%-928萬 | -27.49%1,401.9萬 | -219.49%-3.86億 | -178.49%-6,715萬 | -616.88%-2.55億 |
| 營業外利息收入與支出淨額 | 51.57%-89.2萬 | 14.01%-138.1萬 | -2.26%-655.1萬 | -8.37%-137.2萬 | -11.46%-173.1萬 | -8.29%-184.2萬 | 14.85%-160.6萬 | 23.37%-640.6萬 | 36.16%-126.6萬 | 29.92%-155.3萬 |
| 營業外利息收入 | 193.89%38.5萬 | --1.2萬 | 157.01%27.5萬 | 81.01%14.3萬 | 0.00%1,000 | 385.19%13.1萬 | --0 | 174.36%10.7萬 | 315.79%7.9萬 | 0.00%1,000 |
| 營業外利息支出 | -35.28%127.7萬 | -13.26%139.3萬 | 4.81%682.6萬 | 12.64%151.5萬 | 11.45%173.2萬 | 14.18%197.3萬 | -14.85%160.6萬 | -22.46%651.3萬 | -32.82%134.5萬 | -29.91%155.4萬 |
| 投資淨收益 | -2,206.52%-106.1萬 | -49.28%14萬 | 415.23%76.6萬 | 175.32%23.5萬 | 181.13%30.1萬 | -121.80%-4.6萬 | 20.52%27.6萬 | -171.89%-24.3萬 | -267.06%-31.2萬 | -214.86%-37.1萬 |
| 被指定為現金流套期的金融工具損益 | ||||||||||
| 終止確認可供出售金融資產損益 | ||||||||||
| 聯營企業及其他參股權益產生的收益 | ||||||||||
| 特殊收入（費用） | 0 | -343.70%-2,074.3萬 | ||||||||
| 減：勾銷 | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 343.70%2,074.3萬 | ---- | ---- |
| 其他營業外收入（費用） | -69.00%104.3萬 | -89.97%208.3萬 | 338.98%3,327萬 | 432.23%739.8萬 | -53.94%173萬 | 104.75%336.4萬 | 2,530.13%2,077.8萬 | -84.44%757.9萬 | -97.08%139萬 | 390.98%375.6萬 |
| 稅前利潤 | 68.12%-248.8萬 | -44.37%1,861.9萬 | 117.00%6,892.3萬 | 161.43%5,410.5萬 | 95.72%-1,084.7萬 | 90.54%-780.4萬 | 81.21%3,346.9萬 | -213.02%-4.05億 | -169.63%-8,808.1萬 | -625.17%-2.53億 |
| 所得稅 | -453.94%-1,221.1萬 | -156.40%-531.3萬 | -457.59%-1,022萬 | -5,586.45%-2,348.2萬 | -51.60%39.2萬 | -79.59%345萬 | 161.63%942萬 | -97.77%285.8萬 | -99.57%42.8萬 | 108.48%81萬 |
| 除稅後利潤 | 186.40%972.3萬 | -0.49%2,393.2萬 | 119.38%7,914.3萬 | 187.66%7,758.7萬 | 95.58%-1,123.9萬 | 88.68%-1,125.4萬 | -28.75%2,404.9萬 | -277.00%-4.08億 | -435.72%-8,850.9萬 | -539.76%-2.54億 |
| 持續經營利潤 | 186.40%972.3萬 | -0.49%2,393.2萬 | 119.38%7,914.3萬 | 187.66%7,758.7萬 | 95.58%-1,123.9萬 | 88.68%-1,125.4萬 | -28.75%2,404.9萬 | -277.00%-4.08億 | -435.72%-8,850.9萬 | -539.76%-2.54億 |
| 歸屬于少數股東的淨利潤 | ||||||||||
| 歸屬於母公司的淨利潤 | 186.39%972.3萬 | -0.48%2,393.3萬 | 119.38%7,914.3萬 | 187.66%7,758.7萬 | 95.58%-1,123.8萬 | 88.68%-1,125.5萬 | -28.75%2,404.9萬 | -277.00%-4.08億 | -435.71%-8,850.9萬 | -539.77%-2.54億 |
| 優先股派息 | ||||||||||
| 其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 歸屬于普通股股東的淨利潤 | 186.39%972.3萬 | -0.48%2,393.3萬 | 119.38%7,914.3萬 | 187.66%7,758.7萬 | 95.58%-1,123.8萬 | 88.68%-1,125.5萬 | -28.75%2,404.9萬 | -277.00%-4.08億 | -435.71%-8,850.9萬 | -539.77%-2.54億 |
| 總派息金額 | ||||||||||
| 基本每股收益 | 186.31%1.45 | -0.84%3.55 | 119.33%11.76 | 187.55%11.53 | 95.59%-1.67 | 88.68%-1.68 | -28.97%3.58 | -276.22%-60.85 | -435.11%-13.17 | -538.93%-37.88 |
| 稀釋每股收益 | 185.71%1.44 | 1.14%3.54 | 119.11%11.63 | 186.56%11.4 | 95.59%-1.67 | 88.68%-1.68 | -27.69%3.5 | -286.66%-60.85 | -451.20%-13.17 | -563.08%-37.88 |
| 每股派息 | ||||||||||
| 貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
| 會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |